ENDOSTATIN for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where ENDOSTATIN was used for Lung neoplasm malignant.
Most Reported Side Effects for ENDOSTATIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 21 | 25.6% | 0 | 9 |
| Nausea | 10 | 12.2% | 3 | 1 |
| Bone marrow failure | 7 | 8.5% | 1 | 0 |
| Gastrointestinal disorder | 7 | 8.5% | 0 | 0 |
| Hepatic function abnormal | 7 | 8.5% | 1 | 1 |
| White blood cell count decreased | 7 | 8.5% | 0 | 3 |
| Disease progression | 6 | 7.3% | 3 | 0 |
| Hypertension | 6 | 7.3% | 2 | 0 |
| Leukopenia | 6 | 7.3% | 2 | 0 |
| Vomiting | 6 | 7.3% | 1 | 0 |
| Gastrointestinal toxicity | 5 | 6.1% | 0 | 0 |
Other Indications for ENDOSTATIN
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)